Dr. Mandel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7200 Cambridge St
Houston, TX 77030Phone+1 713-798-8259Fax+1 713-798-7709
Summary
- Dr. Jacob Mandel is a neurologist in Houston, TX and is affiliated with Baylor St. Luke's Medical Center. He received his medical degree from Rush Medical College and has been in practice 9 years. He specializes in neurooncology and is experienced in neuro-oncology.
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2014
- Ohio State University HospitalResidency, Neurology, 2009 - 2012
- Ohio State University HospitalInternship, Internal Medicine, 2008 - 2009
- Rush Medical College of Rush University Medical CenterClass of 2008
Certifications & Licensure
- TX State Medical License 2014 - 2025
- OH State Medical License 2008 - 2014
- American Board of Psychiatry and Neurology Neurology
- UCNSNeuro-Oncology
Publications & Presentations
PubMed
- Low-grade glial/glioneuronal tumor with YAP1::FAM118B fusion: A novel molecular finding.Fouad El-Dana, Kenneth Aldape, Zied Abdullaev, Sameer Anil Sheth, Jacob Mandel
Journal of Neuropathology and Experimental Neurology. 2024-09-20 - 1 citationsVirtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors.James L Rogers, Thomas Wall, Alvina A Acquaye-Mallory, Lisa Boris, Yeonju Kim
Journal of Neuro-Oncology. 2024-04-01 - 1 citationsAggressive human MenG C meningiomas have a molecular counterpart in canines.Akdes S Harmanci, Beth Boudreau, Sean Lau, Shervin Hosseingholi Nouri, Jacob J Mandel
Acta Neuropathologica. 2024-02-20
Press Mentions
- CASSINI Trial Assesses Rivaroxaban for Thromboprophylaxis in Cancer PatientsMarch 13th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: